Home / Data / Women's Health Trial Tracker Women's Health Trial Tracker Women's Health Trial Tracker organizes records from ClinicalTrials.gov API v2 into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 5,000
Last changed 08/26/2026
Update schedule 55 1 * * * UTC
Coverage 05/26/2000–08/25/2026 Record Record Date Vuga Group Change Status Recency Days Public Significance Score Effect of Acupuncture on IVF Pregnancy Outcomes for Women With RIF 08/31/2020 INTERVENTIONAL unchanged 2,186.85 0 Efficacy, Immunogenicity and Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli) 09/03/2020 INTERVENTIONAL unchanged 2,183.85 0 Anti-mullerian Hormone Levels in Healthy Females 09/03/2020 INTERVENTIONAL unchanged 2,183.85 0 Fertility, Hypercoagulability, and Inflammation (FREYA) Registry 09/03/2020 OBSERVATIONAL unchanged 2,183.85 0 Evaluation of Sequencing of Anthracyclines and Taxanes for Locally Advanced HER2-negative Breast Cancer 09/07/2020 INTERVENTIONAL unchanged 2,179.85 0 Improving Women's Function After Pelvic Radiation 09/10/2020 INTERVENTIONAL unchanged 2,176.85 0 Efficacy of Conservative Treatment of Functional Defecatory Disorders in Females With Pelvic Organ Prolapse 09/14/2020 INTERVENTIONAL unchanged 2,172.85 0 A Comparison of Nab-PHP and TCbHP Efficacy in Neoadjuvant Therapy for HER2-positive Early Breast Cancer 09/14/2020 INTERVENTIONAL unchanged 2,172.85 0 Subcutaneous Progesterone in Frozen- Thawed Single Euploid Blastocyst Transfer. 09/16/2020 INTERVENTIONAL unchanged 2,170.85 0 Serosurveillance Study of Maternally Derived Anti-GBS Antibody 09/16/2020 OBSERVATIONAL unchanged 2,170.85 0 Improving Patient-Centered Communication in Breast Cancer Through Patient and Provider Interventions 09/16/2020 INTERVENTIONAL unchanged 2,170.85 0 Natural Versus Programmed Frozen Embryo Transfer (NatPro) 09/16/2020 INTERVENTIONAL unchanged 2,170.85 0 Fusion Ultrasound for Diagnosis and Monitoring of Endometriosis Lesions 09/18/2020 OBSERVATIONAL unchanged 2,168.85 0 Impact of Web Application Support Versus Standard Management on Compliance With Adjuvant Hormone Therapy at 18 Months in Patients Treated for Breast Cancer 09/18/2020 INTERVENTIONAL unchanged 2,168.85 0 The Efficacy of Lymph Node Dissection for Stage IIICr of Cervical Cancer(CQGOG0103) 09/18/2020 INTERVENTIONAL unchanged 2,168.85 0 Improving Therapeutic Learning for PTSD 09/22/2020 INTERVENTIONAL unchanged 2,164.85 0 RCT Evaluating Standardized Counseling on Early Discontinuation for Irregular Bleeding in Nexplanon Users 09/22/2020 INTERVENTIONAL unchanged 2,164.85 0 Slow Heart Registry of Fetal Immune-mediated High Degree Heart Block 09/22/2020 OBSERVATIONAL unchanged 2,164.85 0 Remission Factors in Anorexia Nervosa 09/23/2020 OBSERVATIONAL unchanged 2,163.85 0 Prophylactic Laparoscopic Suspension After McCall 09/23/2020 INTERVENTIONAL unchanged 2,163.85 0 Biweekly Actinomycin-D Treatment or Multi-day Methotrexate Protocol in Low-risk Gestational Trophoblastic Neoplasia 09/24/2020 INTERVENTIONAL unchanged 2,162.85 0 Prospective Study of Immune Alterations in Operable Breast and Ovarian Carcinoma 09/24/2020 OBSERVATIONAL unchanged 2,162.85 0 Combined Immunotherapies in Metastatic ER+ Breast Cancer 09/24/2020 INTERVENTIONAL unchanged 2,162.85 0 Adjuvant Therapy With Abemaciclib + SOC ET vs. SOC ET in Clinical or Genomic High Risk, HR+/HER2- EBC 09/25/2020 INTERVENTIONAL unchanged 2,161.85 0 Comparison of Proton or Intensity Modulated Radiation Therapy After Surgery for Endometrial or Cervical Cancer 09/28/2020 INTERVENTIONAL unchanged 2,158.85 0 Phase II Study of Neoadjuvant ArOMatase Inhibitor Therapy for ER+ Breast Cancer (NAOMI) 09/29/2020 INTERVENTIONAL unchanged 2,157.85 0 Choosing Ovarian Preservation or Removal Before Surgery for Endometrial Cancer 09/30/2020 OBSERVATIONAL unchanged 2,156.85 0 Use of an Intrauterine Manipulator and Its Correlation with Positive Peritoneal Cytology in Early Stage Endometrial Cancers 09/30/2020 INTERVENTIONAL unchanged 2,156.85 0 Treatment for Aerobic Vaginitis by Using Bofukang Vaginal Suppository 10/05/2020 INTERVENTIONAL unchanged 2,151.85 0 Human Papilloma Virus (HPV) Circulating Tumor DNA (ctDNA) in Cervical Cancer 10/05/2020 OBSERVATIONAL unchanged 2,151.85 0 Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial 10/05/2020 INTERVENTIONAL unchanged 2,151.85 0 Study of Pembrolizumab Combination With Chemotherapy in Platinum-sensitive Recurrent Low-grade Serous Ovarian Cancer 10/05/2020 INTERVENTIONAL unchanged 2,151.85 0 Efficacy and Safety of Dose-dense Chemotherapy (ddEC-ddP) for Neoadjuvant Chemotherapy of HER2-negative Breast Cancer 10/06/2020 INTERVENTIONAL unchanged 2,150.85 0 Twin A Breech External Cephalic Version Intervention Trial (TWEXIT) 10/08/2020 OBSERVATIONAL unchanged 2,148.85 0 A Vaccine (PDS0101) and Chemoradiation for the Treatment of Stage IB3-IVA Cervical Cancer, the IMMUNOCERV Trial 10/08/2020 INTERVENTIONAL unchanged 2,148.85 0 Comparative Effectiveness Study of Spironolactone Versus Doxycycline for Acne 10/09/2020 INTERVENTIONAL unchanged 2,147.85 0 Ovarian Reserve and Bariatric Surgery 10/12/2020 OBSERVATIONAL unchanged 2,144.85 0 Hypofractionated External-beam RadiOtherapy for Intact Cervical Cancer (HEROICC-Trial): A Feasibility Study 10/12/2020 INTERVENTIONAL unchanged 2,144.85 0 Pilot Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) in Severe Left Congenital Diaphragmatic Hernia (CDH) 10/12/2020 INTERVENTIONAL unchanged 2,144.85 0 Developing an EEG Paradigm to Study Prediction Error in Anorexia Nervosa 10/12/2020 INTERVENTIONAL unchanged 2,144.85 0 PreOperative Endocrine Therapy for Individualised Care With Abemaciclib 10/14/2020 INTERVENTIONAL unchanged 2,142.85 0 Prospective Study of MAstectomy With Reconstruction Including Robot Endoscopic Surgery 10/14/2020 OBSERVATIONAL unchanged 2,142.85 0 Preconception Lifestyle Interventions to Improve Future Metabolic Health (Before the Beginning) 10/14/2020 INTERVENTIONAL unchanged 2,142.85 0 Single-incision Versus Retropubic Mid-Urethral Sling (Solyx) for SUI During Minimally Invasive Sacrocolpopexy 10/14/2020 INTERVENTIONAL unchanged 2,142.85 0 Uterine Manipulation During Minimally Invasive Surgery for Early Stage Endometrial Cancer 10/14/2020 INTERVENTIONAL unchanged 2,142.85 0 Impact of HPV Vaccination on Prevention of Cervical HPV Infection in Sikkim, India 10/19/2020 OBSERVATIONAL unchanged 2,137.85 0 A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab 10/19/2020 INTERVENTIONAL unchanged 2,137.85 0 What is the Best Interval to Screen Women 45-49 and 70-74 for Breast Cancer? 10/19/2020 INTERVENTIONAL unchanged 2,137.85 0 Assessment of Drug-drug Interactions Between Masculinizing Hormone Therapy and Antiretroviral Agents Concomitantly for Pre-exposure Prophylaxis Among Transgender Men 10/20/2020 INTERVENTIONAL unchanged 2,136.85 0 Fresh Corneal Lenticule Implantation and Autologous Serum - Case Report 10/20/2020 INTERVENTIONAL unchanged 2,136.85 0
Source U.S. National Library of Medicine, ClinicalTrials.gov API v2 · official record · retrieved 08/26/2026 · upstream last modified 08/26/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. National Library of Medicine
Required notice Study records are informational and do not provide diagnosis, treatment advice, or an assessment of individual risk. What we add We compute Vuga Group, Change Status, Recency Days, Public Significance Score using the documented compute method. · methodology